Q32 Bio Inc. (QTTB) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	53.7M	53.7M	—	(6.7M)	6.7M
Cost of Revenue	85.0K	—	—	—	—
Gross Profit	53.7M	53.7M	—	(6.7M)	6.7M
Operating Expenses
R&D Expense	14.3M	19.2M	48.1M	31.7M	35.8M
SG&A Expense	17.9M	17.7M	18.0M	9.9M	10.1M
General & Admin Expense	17.9M	17.7M	18.0M	9.9M	10.1M
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	(85.0K)	—	—	—	—
Total Operating Expenses	32.2M	36.8M	66.1M	41.6M	45.9M
Cost and Expenses	32.3M	36.8M	66.1M	41.6M	45.9M
Operating Income (EBIT)	21.5M	16.9M	(66.1M)	(48.3M)	(39.2M)
Non-Operating
Interest Income	900.0K	2.2M	3.9M	—	—
Interest Expense	1.3M	1.1M	1.1M	—	—
Net Interest Income	(400.0K)	1.1M	2.8M	—	—
Other Non-Op Income/Expense	12.3M	12.9M	18.4M	(5.2M)	(3.5M)
Non-Operating Income (excl Interest)	(12.7M)	(14.0M)	(21.1M)	—	—
EBT (Pre-Tax Income)	33.8M	29.8M	(47.7M)	(53.4M)	(42.7M)
Income Tax Expense	—	—	21.0K	318.0K	62.0K
Bottom Line
Net Income	33.8M	29.8M	(47.7M)	(53.7M)	(42.8M)
Earnings from Cont. Ops	33.8M	29.8M	(47.7M)	(53.7M)	(42.8M)
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	33.8M	29.8M	(63.5M)	(53.7M)	(42.8M)
Per Share
Basic EPS	$2.79	$2.42	($5.12)	($4.51)	($3.59)
Diluted EPS	$2.79	$2.42	($6.58)	($4.51)	($3.59)
Revenue Per Share	$3.81	$4.37	$0.00	($0.56)	$0.56
Shares
Basic Shares Outstanding	14.1M	12.3M	9.3M	11.9M	11.9M
Diluted Shares Outstanding	14.1M	12.3M	9.7M	11.9M	11.9M
Profitability Metrics
EBITDA	34.6M	31.3M	(44.5M)	(47.8M)	(38.9M)
D&A	446.0K	391.0K	487.0K	499.0K	370.0K
EBIT	34.2M	30.9M	(45.0M)	(48.3M)	(39.2M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026